Topical Non-Steroidal Anti-Inflammatory Drugs Market – Global Industry Trends & Forecast to 2029

 Topical Non-Steroidal Anti-Inflammatory Drugs Market is expected to gain market growth in the forecast period of 2020 to 2029. Data Bridge Market Research analyses that the topical non-steroidal anti-inflammatory drugs market was valued at USD 2,517.73 million in 2021 and is expected to reach USD 3,776.90 million by 2029, registering a CAGR of 5.20% during the forecast period of 2022 to 2029.

The Topical Non-Steroidal Anti-Inflammatory Drugs Market Scope and Size 

Market Definition

Nonsteroidal anti-inflammatory drugs (NSAIDs) are creams, gels, rubs, solutions, or sprays that include a nonsteroidal anti-inflammatory agent and are designed to be administered directly to the skin overlaying a painful joint or bone area. They're used to treat arthritic symptoms including inflammation, edema, and stiffness and decrease pain. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) can also be used to treat actinic keratosis (a precancerous patch of thick, scaly or crusted skin).

Market Segmentation

The topical non-steroidal anti-inflammatory drugs market is segmented on the basis of indication, dosage form, drug type, age group, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Anti-inflammatory
  • Analgesic
  • Swelling
  • Stiffness
  • Skin Infections

Drug Type

  • Branded
  • Generics

Dosage Form

  • Creams
  • Gel
  • Ointment
  • Spray
  • Rubs
  • Solution
  • Others

Age Group

  • Pediatric
  • Adult
  • Geriatric

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Get the sample copy of Report here :  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-non-steroidal-anti-inflammatory-drugs-market

 

Market Analysis and Insights Topical Non-Steroidal Anti-Inflammatory Drugs Market

The topical non-steroidal anti-inflammatory drugs market is analysed and market size insights and trends are provided by country, indication, dosage form, drug type, age group, end-users and distribution channel as referenced above.

North America dominates the topical non-steroidal anti-inflammatory drugs market because of the growing number of research and development activities and presence of major key players in this region. Additionally the rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to surging government awareness programs and the increasing geriatric population in this region. Also, the development of healthcare infrastructure and the increasing number of generic drugs will further propel the market's growth rate in this region.

Topical Non-Steroidal Anti-Inflammatory Drugs Market Country Level Analysis

The countries covered in the topical non-steroidal anti-inflammatory drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.  

Topical Non-Steroidal Anti-Inflammatory Drugs Market Share Analysis

The Topical non-steroidal anti-inflammatory drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical non-steroidal anti-inflammatory drugs market

 Key Players Topical Non-Steroidal Anti-Inflammatory Drugs Market

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France), Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Zydus Cadila (India)
  • Boehringer Ingelheim International GmbH. (Germany).

Get Full Access of Report: https://www.databridgemarketresearch.com/reports/global-topical-non-steroidal-anti-inflammatory-drugs-market

 

MAJOR TOC OF THE REPORT

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six: Global Topical Non-Steroidal Anti-Inflammatory Drugs Market by Product & Procedure type

Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-topical-non-steroidal-anti-inflammatory-drugs-market

 

 Browse Related Reports@

Osteoarthritic Pain Management Treatment Market

Osteoarthritic Pain Market

Actinic Keratosis Treatment Market

Bone Densitometer Devices Market

 About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com


Comments

Post a Comment

Popular posts from this blog

Menopausal Disorder Treatment Market share, Trajectory, Analytics Report, Analysis, & Forecast 2029

Image
  The   Menopausal Disorder Treatment Market   will expect to grow at a rate of the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the menopausal disorder treatment market was valued at USD 11,860.10 million in 2021 and is expected to reach USD 21,790.13 million by 2029, registering a CAGR of 7.90% during the forecast period of 2022 to 2029. The Menopausal Disorder Treatment Market Scope and Size Menopausal Syndrome refers to the symptoms that accompany the physiological changes that occur in a woman's body when her reproductive years come to an end. Menopause is a natural female hormone deficiency that happens between the ages of 45 and 55. It is a typical result of the ageing process. The ovaries gradually become less active and produce less sex hormone throughout this time (estrogen and progesterone). As a result, menstruation is no longer possible. If a woman has not had a monthly cycle for a year and has no underlying cause, she is us...
Read more

Menopausal Disorder Treatment Market Size, Share, Forecast, & Industry Analysis 2029

Image
  The  Menopausal Disorder Treatment Market   will expect to grow at a rate of the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the menopausal disorder treatment market was valued at USD 11,860.10 million in 2021 and is expected to reach USD 21,790.13 million by 2029, registering a CAGR of 7.90% during the forecast period of 2022 to 2029 . The Menopausal Disorder Treatment Market Scope and Size Menopausal Syndrome refers to the symptoms that accompany the physiological changes that occur in a woman's body when her reproductive years come to an end. Menopause is a natural female hormone deficiency that happens between the ages of 45 and 55. It is a typical result of the ageing process. The ovaries gradually become less active and produce less sex hormone throughout this time (estrogen and progesterone). As a result, menstruation is no longer possible. If a woman has not had a monthly cycle for a year and has no underlying cause, she is us...
Read more

Menopausal Disorder Treatment Market Size, Share, Forecast, & Industry Analysis 2029

Image
  The  Menopausal Disorder Treatment Market   will expect to grow at a rate of the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the menopausal disorder treatment market was valued at USD 11,860.10 million in 2021 and is expected to reach USD 21,790.13 million by 2029, registering a CAGR of 7.90% during the forecast period of 2022 to 2029. The Menopausal Disorder Treatment Market Scope and Size Menopausal Syndrome refers to the symptoms that accompany the physiological changes that occur in a woman's body when her reproductive years come to an end. Menopause is a natural female hormone deficiency that happens between the ages of 45 and 55. It is a typical result of the ageing process. The ovaries gradually become less active and produce less sex hormone throughout this time (estrogen and progesterone). As a result, menstruation is no longer possible. If a woman has not had a monthly cycle for a year and has no underlying cause, she is usu...
Read more